Allogeneic effector/memory Th-1 cells impair FoxP3(+) regulatory T lymphocytes and synergize with chaperone-rich cell lysate vaccine to treat leukemia

作者：Janikashvili Nona; LaCasse Collin J; Larmonier Claire; Trad Malika; Herrell Amanda; Bustamante Sara; Bonnotte Bernard; Har Noy Michael; Larmonier Nicolas; Katsanis Emmanuel^*

来源：Blood, 2011, 117(5): 1555-1564.

DOI：10.1182/blood-2010-06-288621

Therapeutic strategies combining the induction of effective antitumor immunity with the inhibition of the mechanisms of tumor-induced immunosuppression represent a key objective in cancer immunotherapy. Herein we demonstrate that effector/memory CD4(+) T helper-1 (Th-1) lymphocytes, in addition to polarizing type-1 antitumor immune responses, impair tumor-induced CD4(+)CD25(+)FoxP3(+) regulatory T lymphocyte (Treg) immunosuppressive function in vitro and in vivo. Th-1 cells also inhibit the generation of FoxP3(+) Tregs from naive CD4(+)CD25(-)FoxP3(-) T cells by an interferon-gamma-dependent mechanism. In addition, in an aggressive mouse leukemia model (12B1), Th-1 lymphocytes act synergistically with a chaperone-rich cell lysate (CRCL) vaccine, leading to improved survival and long-lasting protection against leukemia. The combination of CRCL as a source of tumor-specific antigens and Th-1 lymphocytes as an adjuvant has the potential to stimulate efficient specific antitumor immunity while restraining Treg-induced suppression. (Blood. 2011; 117(5): 1555-1564)

• 出版日期2011-2-3